GPTHEALTH161.06

GPT Healthcare Limited

· Pharma & Health
AnnualQuarterly₹ CrorePeersGKSLSHALBYINDRAMEDCOLOTUSEYEARTEMISMEDDRAGARWQKMCSHILKOVAIMcap ₹1,322 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Revenue from Operations400.2407.1472.5491.6
Other Income5.38.56.06.4
Total Income405.5415.6478.5498.1
Expenses
+ Cost of Materials Consumed83.078.889.893.3
+ Employee Benefit Expense68.973.084.487.2
+ Finance Costs7.13.58.28.8
+ Depreciation & Amortisation18.019.027.127.8
+ Other Expenses160.5171.9214.2220.2
Total Expenses337.4346.2423.7437.2
EBITDA87.883.484.291.0
EBIT69.964.357.163.2
Profit
PBT before Exceptional Items68.069.354.860.9
Pretax Income68.069.354.860.9
+ Current Tax11.912.112.615.3
+ Deferred Tax8.47.30.0-1.7
Tax Expense20.319.412.613.6
Net Income47.849.942.247.3
+ Net Income — Continuing Ops47.849.942.247.3
+ Other Comprehensive Income0.0-0.0-0.1-0.1
Total Comprehensive Income47.849.942.147.1
Per Share
Basic EPS5.966.085.155.76
Diluted EPS5.966.085.155.76
Other Comprehensive Income — detail
+ Other Comprehensive Income-0.0-0.1-0.1
+ Items NOT to be Reclassified to P&L0.0-0.1-0.2
+ Tax on Items NOT to be Reclassified-0.0-0.1
+ Tax on Items NOT to be Reclassified — alt tag0.0
+ Tax on Items to be Reclassified0.00.0-0.0
Per Share — as-filed variants
Basic EPS — Continuing Operations5.966.085.155.76
Diluted EPS — Continuing Operations5.966.085.155.76
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit317.2328.3382.8398.4
Gross Margin %79.2780.6481.0081.03
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)68.069.354.860.9
Net Income Adj (tax-effected)47.849.942.247.3
EPS Adj5.966.085.155.76
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value10.0010.0010.0010.00
Paid Up Equity Capital82.182.182.182.1
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.